Methotrexate and Folic Acid Therapy

Mechanism and Rationale

Folic acid supplementation is strongly recommended for all patients on methotrexate therapy to reduce toxicity without compromising treatment efficacy, as suggested by the American College of Rheumatology 1, 2
Methotrexate is a folate antagonist that inhibits folate-dependent purine and pyrimidine synthesis pathways, which is part of its therapeutic mechanism but also the source of many side effects, according to the American College of Nutrition 2
Folic acid supplementation helps replenish folate stores depleted by methotrexate, reducing adverse effects while maintaining therapeutic efficacy, as recommended by the American College of Rheumatology 1, 2

Dosing Recommendations

The standard recommendation for folic acid dosage is 1-5 mg daily, as suggested by the American Academy of Dermatology 3, 4
Folic acid should be given daily except on the day(s) of methotrexate administration to avoid potential interference with efficacy, according to the American Academy of Dermatology 5, 6
At least 5 mg of folic acid per week is strongly recommended by rheumatology guidelines, as suggested by the American College of Rheumatology 1, 7

Important Clinical Considerations

Folic acid is preferred over folinic acid for routine supplementation due to lower cost and similar effectiveness, as recommended by the American Academy of Dermatology 5
Lack of folate supplementation is a major risk factor for methotrexate-induced hematologic toxicity, according to the American Academy of Dermatology 3, 4
Regular monitoring of liver function, blood counts, and renal function remains essential even with folate supplementation, as suggested by the American Academy of Dermatology 8, 9

Methotrexate Mechanism and Folic Acid Supplementation

Mechanism of Action of Methotrexate

Methotrexate functions as a folic acid antagonist, which interferes with purine and pyrimidine synthesis, thus impairing nucleotide production, as recommended by the American Academy of Allergy and Clinical Immunology 10, 11
At low doses used for inflammatory conditions, methotrexate primarily decreases proliferation of lymphoid cells through direct immunosuppressive effects rather than affecting epidermal cells, according to the American Academy of Dermatology 12
Methotrexate also increases endogenous adenosine, an anti-inflammatory molecule, through inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase, as stated by the American Academy of Dermatology 12

Necessity of Folic Acid Supplementation

The American Academy of Dermatology strongly recommends folate supplementation for all patients taking methotrexate to reduce the incidence of adverse effects, with a strength of evidence supported by the Journal of Allergy and Clinical Immunology 11

Patient Considerations

Patients with renal insufficiency require dose adjustments of methotrexate, as impaired clearance increases toxicity risk, as recommended by the British Association of Dermatologists 13
Nausea is one of the most common side effects of methotrexate (up to 25% of patients), and folic acid supplementation can help reduce this symptom, according to the British Association of Dermatologists 13

Methotrexate and Folic Acid Interaction Guidelines

Introduction to Methotrexate and Folic Acid Interaction

Folic acid supplementation at a minimum of 5 mg per week is strongly recommended for all patients receiving methotrexate therapy, as it significantly reduces gastrointestinal and hepatic toxicity without compromising therapeutic efficacy, according to the American College of Rheumatology 14

Folic Acid Supplementation Recommendations

For patients with rheumatoid arthritis, prescribe at least 5 mg folic acid per week for all patients on methotrexate therapy, as recommended by the European League Against Rheumatism 14, 15
Higher doses (7-35 mg/week) may be needed with higher methotrexate doses (>15 mg/week), as the protective effect is most significant at lower methotrexate doses (<10 mg/week), based on evidence from the American College of Rheumatology 14
Meta-analysis of 788 RA patients demonstrated that folic acid supplementation reduces gastrointestinal side effects (OR 0.42) and hepatotoxicity (OR 0.17) without reducing methotrexate efficacy, as reported by the American College of Rheumatology 14

Special Considerations

For ectopic pregnancy treatment, folic acid should be avoided during methotrexate treatment, as it may directly counteract methotrexate's primary action as a folate antagonist in this acute, high-dose setting, according to the American College of Emergency Physicians 16, 17

Toxicity Reduction

Hepatotoxicity: Folic acid supplementation reduces hepatic adverse effects by 35.8% (95% CI -0.467 to -0.248), with 1 mg/day showing significant protective effect (OR 0.17), based on evidence from the American Association for the Study of Liver Diseases 14
Gastrointestinal effects: Reduction in nausea, stomatitis, and other GI symptoms, particularly with doses of 7-35 mg/week, as reported by the American Gastroenterological Association 14

Impact on Efficacy

Folic acid at ≤5 mg/week does not reduce methotrexate efficacy in rheumatoid arthritis or psoriasis, according to the National Psoriasis Foundation 14, 15
Critical caveat: Folinic acid at doses >5 mg/week was associated with increased tender and swollen joints (OR 6.27 and 5.3 respectively), suggesting potential interference with efficacy at higher doses, as reported by the American College of Rheumatology 14

Practical Implementation

Start with 5 mg folic acid weekly (can be given as 1 mg daily for 5-6 days, avoiding methotrexate day), as recommended by the American College of Rheumatology 14
For patients on methotrexate >15 mg/week, consider increasing to 7-10 mg folic acid weekly, based on evidence from the European League Against Rheumatism 14
Regular monitoring of liver function (ALT/AST), CBC, and creatinine remains essential every 1-1.5 months initially, then every 1-3 months, even with folic acid supplementation, as recommended by the American College of Rheumatology 15

Folic Acid and Methotrexate Administration Guidelines

Introduction to Folic Acid and Methotrexate

Folic acid should be given daily except on the day(s) of methotrexate administration because, in theory, folic acid may compete for cellular uptake of methotrexate when given on the same day, potentially reducing its therapeutic efficacy 18, 19, 20, 21

Mechanistic Rationale

Folic acid may theoretically compete with methotrexate for cellular uptake when both are present simultaneously, potentially diminishing methotrexate's ability to enter cells and exert its therapeutic effect 18, 19, 20, 21

Evidence-Based Dosing Schedule

Folic acid supplementation at 1-5 mg daily is strongly recommended, with administration on all days except the day(s) when methotrexate is taken 22, 23
The British Association of Dermatologists (2016) explicitly states that folic acid may compete for cellular uptake of methotrexate when given on the same day, providing the theoretical basis for this practice 18, 19, 20, 21
The American Academy of Dermatology guidelines (2020) recommend folate supplementation daily except for the days in which methotrexate is given to avoid influencing efficacy 23

Clinical Evidence on Efficacy

Studies have shown that folic acid supplementation does not affect methotrexate efficacy when dosed appropriately (≤5 mg/week), with most evidence derived from rheumatoid arthritis patients 18, 19, 20, 21

Important Clinical Caveats

Folic acid is preferred over folinic acid (leucovorin) for routine supplementation due to lower cost and similar effectiveness in preventing side effects 18
Prescribe folic acid 1-5 mg daily, instructing patients to skip the dose on the day they take methotrexate (and the day after if using split-dose methotrexate regimens) 22, 23

Benefits of Folic Acid Supplementation

Reduces gastrointestinal side effects (nausea, stomatitis) and hepatotoxicity without compromising therapeutic efficacy 23, 18

Common Pitfall to Avoid

Do not confuse routine folic acid supplementation with leucovorin rescue therapy, as leucovorin (folinic acid) is the antidote for methotrexate overdose or severe toxicity and should be administered immediately in those situations, regardless of timing concerns 22

Folic Acid Supplementation in Methotrexate Therapy

Introduction to Folic Acid Dosing

The American Academy of Dermatology recommends folic acid supplementation at 1-5 mg daily, given on all days except the day(s) when methotrexate is administered, for patients taking methotrexate daily 24
Daily methotrexate dosing has been shown to be less effective than weekly dosing and causes more liver enzyme elevation, according to the American Academy of Dermatology 24
The American Academy of Dermatology strongly prefers weekly dosing over daily dosing for better efficacy and tolerability 24

Folic Acid Supplementation Guidelines

The American Academy of Dermatology recommends using folic acid, not folinic acid, for routine supplementation, as folic acid is less expensive with similar effectiveness 24
The American Academy of Dermatology advises against using folinic acid for routine supplementation, as it is more expensive and may reduce efficacy at higher doses 24
The American Academy of Dermatology warns against giving folic acid on the same day as methotrexate, as this may compromise therapeutic effect 24

Monitoring and Safety

The American Academy of Dermatology recommends continuing regular monitoring, including liver function tests, complete blood count, and renal function every 3-6 months, even with folic acid supplementation 25
The American Academy of Dermatology advises against continuing daily methotrexate dosing if possible, as weekly dosing is superior in efficacy and tolerability 24

Folic Acid Supplementation Guidelines for Methotrexate Therapy

Guideline-Based Recommendations for Folate Supplementation

The American College of Rheumatology recommends increased doses of folic/folinic acid for patients not tolerating methotrexate, with no mention of methylfolate as an acceptable alternative 26, 27, 28
The American Academy of Dermatology recommends administration of folic acid or folinic acid to reduce GI and hepatic adverse effects, specifically stating that folic acid is preferred over folinic acid due to lower cost and similar effectiveness 29
The British Association of Dermatologists guidelines recommend folic acid supplementation for all patients on methotrexate, with doses varying between 5 mg weekly and 5 mg daily based on clinical trials 30

Dosing and Administration Guidelines

Prescribe folic acid 1-5 mg daily on all days except the day(s) when methotrexate is administered, as folic acid may theoretically compete for cellular uptake of methotrexate when given simultaneously 29, 30
Folic acid is preferred over folinic acid for routine supplementation due to lower cost and similar effectiveness, and folinic acid at doses >5 mg/week may actually reduce methotrexate efficacy 29